Resmetirom and Metabolic Dysfunction‑Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals

dataset

posted on 2024-08-30, 06:32 authored by Skye MarshallSkye Marshall

A narrative review and discussion by international experts on resmetirom for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).

History

Publisher DOI

https://doi.org/10.1007/s13679-024-00582-z

Open access

Link to full text

https://link.springer.com/article/10.1007/s13679-024-00582-z

Publication classification

Narrative review

Usage metrics

Keywords

Liver disease Steatohepatitis Resmetirom Narrative review

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM